SK LIFE SCIENCE & DESIGN

Trademark usage description

medicines for human purposes and veterinary preparations, biological preparations for medical purposes, chemical preparations for pharmaceutical purpo Read More

Vienna Information

3 . 13 . 1

ButterfliesPapillons

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information

Class [005]
Medicines for human purposes and veterinary preparations, biological preparations for medical purposes, chemical preparations for pharmaceutical purposes, medical preparations of trace elements for human and animal use, biotechnological preparations for medical purposes, chemical preparations for medicinal purposes, chemical preparations for medical or veterinary purposes, therapeutic drugs and agents, chemico-pharmaceutical preparations, bacteriological preparations for medical and veterinary use, all of the foregoing being for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Arachnoid cysts, attention deficit hyperactivity disorder(ADHD), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, Alzheimer's, Huntington's disease, Parkinson's, Tourette's', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (HIV) treatment-induced diabetes, latent autoimmune diabetes in adults (LADA), nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NAFLD), hypoglycemia unawareness (HA), restrictive lung disease, diabetes development in subjects with congenital or HIV-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (Syndrome X); biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for use as pharmaceutical preparations for general health and well being; blood solvent; chemical preparations for sanitary use for preventing pathogenic infections in humans and animals; pharmaceutical preparations for immunity adjustment; vitamin preparations; human and veterinary vaccines for bacterial, fungal, viral and parasitic infections; dietary supplements for general health and well-being.

Classification kind code

Class [042]
Conducting technical project studies namely, conducting clinical trials for others; research and development of new products for others; testing, inspection, and research of pharmaceuticals, cosmetics and foodstuff; research relating to pharmaceuticals; medical research services; research and development of technology for medicinal chemical manufacturing; research for medical products; providing information on the test, inspection, and research of medical products; research and development in the pharmaceutical and biotechnology fields; pharmaceutical product evaluation; medical product testing; research relating to biotechnology; development of biotechnology; biotechnology services, namely biotechnology consultation, laboratory research and analysis in the field of biotechnology; biochemistry research services; biochemical analysis; development and test of chemical production methods; chemical analysis; chemical laboratories; chemical research.

Classification kind code

Mark Details

Serial Number

1894412

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 9^th Dec 2021	Approval Notice Sent
Submitted for opposition 26 on 9^th Dec 2021	Approved
Submitted for opposition 135 on 12^th Jul 2021	Amendment to Application
Submitted for opposition 15 on 29^th Mar 2021	Correspondence Created
Submitted for opposition 15 on 4^th Jun 2020	Correspondence Created
Submitted for opposition 22 on 3^rd Oct 2019	Search Recorded
Submitted for opposition 20 on 3^rd Oct 2019	Examiner's First Report
Submitted for opposition 31 on 24^th Apr 2018	Formalized
Submitted for opposition 1 on 19^th Apr 2018	Created
Submitted for opposition 30 on 18^th Apr 2018	Filed